Company · CIK 0001638287 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
MetaVia Inc. · MTVA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 8, 2026 AForm 4 → | Jun 8, 6:33 pm EDT | James Patrick TursiDirector | 17,186 | — | — | 20,568 | — | |
| Jun 8, 2026 AForm 4 → | Jun 8, 6:33 pm EDT | D Gordon StricklandDirector | 17,186 | — | — | 21,339 | — | |
| Jun 8, 2026 AForm 4 → | Jun 8, 6:32 pm EDT | Michael SalsburyDirector | 17,186 | — | — | 21,338 | — | |
| Jun 8, 2026 AForm 4 → | Jun 8, 6:31 pm EDT | Jason L GrovesDirector | 17,186 | — | — | 21,338 | — | |
| Jun 8, 2026 AForm 4 → | Jun 8, 6:30 pm EDT | Andrew I KovenDirector | 17,186 | — | — | 21,339 | — | |
| Jun 8, 2026 AForm 4 → | Jun 8, 6:29 pm EDT | Mark A GlickmanDirector | 17,186 | — | — | 20,629 | — | |
| Feb 8, 2018 PForm 4 → | Feb 12, 4:40 pm EST | Seth RenoChief Commercial Officer | 14,286 | $7.00 | $100,002 | 18,286 | +357% | plan? |
| Feb 8, 2018 PForm 4 → | Feb 12, 4:31 pm EST | Steven R. Gullans Ph.D.Interim President & CEO, Director | 71,429 | $7.00 | $500,003 | 930,252 | +8.32% | plan? |
| Aug 14, 2017 MForm 4 → | Aug 16, 4:10 pm EDT | Jeffrey S MathiesenChief Financial Officer | 3,207 | $3.59 | $11,513 | 14,134 | — | plan? |
| Aug 10, 2017 MForm 4/A → | Aug 15, 4:22 pm EDT | Jeffrey S MathiesenChief Financial Officer | 3,000 | $3.59 | $10,770 | 10,927 | — | plan? |
| Aug 10, 2017 MForm 4 → | Aug 11, 4:07 pm EDT | Jeffrey S MathiesenChief Financial Officer | 3,000 | $3.59 | $10,770 | 10,927 | — | plan? amended |
| Jul 31, 2017 MForm 4 → | Aug 2, 4:11 pm EDT | Charles Bisgaier Ph.D.Chief Scientific Off. & Chair, Director, 10% Owner | 4,474 | $1.34 | $6,013 | 1,248,914 | — | plan? |
| Mar 10, 2017 PForm 4 → | Mar 14, 6:07 pm EDT | Andy SassineDirector | 21,119 | $9.47 | $199,997 | 136,264 | +18.3% | plan? |
| Mar 10, 2017 PForm 4 → | Mar 14, 5:57 pm EDT | Pedro LichtingerDirector | 10,559 | $9.47 | $99,994 | 59,833 | +21.4% | plan? |
| Mar 10, 2017 PForm 4 → | Mar 14, 5:46 pm EDT | P. Kent HawrylukDirector | 25,000 | $9.47 | $236,750 | 81,889 | +43.9% | plan? |
| Mar 10, 2017 PForm 4 → | Mar 14, 5:33 pm EDT | Steven R. Gullans Ph.D.Director | 52,798 | $9.47 | $499,997 | 858,823 | +6.55% | plan? |
| Feb 1, 2017 JForm 4 → | Feb 3, 4:25 pm EST | Kenneth W KouskyDirector | 211,834 | — | — | 6,463 | — | plan? |
| Aug 10, 2016 PForm 4 → | Aug 12, 1:27 pm EDT | P. Kent HawrylukDirector | 25,000 | $10.00 | $250,000 | 56,889 | +78.4% | plan? |
| Aug 10, 2016 CJForm 4 → | Aug 12, 1:27 pm EDT | P. Kent HawrylukDirector | 31,889 | $6.71 | $163,839 | 31,889 | — | plan? |
| Aug 10, 2016 CJForm 4 → | Aug 12, 1:24 pm EDT | Andy SassineDirector | 115,145 | $6.71 | $268,672 | 115,145 | — | plan? |
| Aug 10, 2016 PForm 4 → | Aug 12, 1:19 pm EDT | Pedro LichtingerDirector | 10,000 | $10.00 | $100,000 | 49,274 | +25.5% | plan? |
| Aug 10, 2016 CForm 4 → | Aug 12, 1:19 pm EDT | Pedro LichtingerDirector | 39,274 | $6.71 | $263,368 | 39,274 | — | plan? |
| Aug 10, 2016 PForm 4 → | Aug 12, 1:15 pm EDT | Kenneth W KouskyDirector | 1,000 | $10.00 | $10,000 | 1,000 | — | plan? |
| Aug 10, 2016 CJForm 4 → | Aug 12, 1:15 pm EDT | Kenneth W KouskyDirector | 222,769 | $6.71 | $853,862 | 116,891 | — | plan? |
| Aug 10, 2016 PForm 4 → | Aug 12, 1:09 pm EDT | Steven R. Gullans Ph.D.Director | 500,000 | $10.00 | $5,000,000 | 806,025 | +163% | plan? |
| Aug 10, 2016 CForm 4 → | Aug 12, 1:09 pm EDT | Steven R. Gullans Ph.D.Director | 306,025 | $6.71 | $2,052,173 | 306,025 | — | plan? |
| Aug 10, 2016 PForm 4 → | Aug 12, 1:06 pm EDT | Seth RenoChief Commercial Officer | 4,000 | $10.00 | $40,000 | 4,000 | — | plan? |
| Aug 10, 2016 PForm 4 → | Aug 12, 1:01 pm EDT | Mina SoochPresident & CEO, Director | 52,500 | $10.00 | $525,000 | 693,732 | +8.19% | plan? |
| Aug 10, 2016 CJForm 4 → | Aug 12, 1:01 pm EDT | Mina SoochPresident & CEO, Director | 39,431 | $6.71 | $190,132 | 39,431 | — | plan? |
| Aug 10, 2016 CJForm 4 → | Aug 12, 12:56 pm EDT | Carmen Daniela OniciuVice President | 2,482 | $6.71 | $1,643 | 152,401 | — | plan? |
| Aug 10, 2016 PForm 4 → | Aug 12, 12:54 pm EDT | David LowenschussChief Legal Off. & Secretary | 11,120 | $10.00 | $111,200 | 806,247 | +1.40% | plan? |
| Aug 10, 2016 PForm 4 → | Aug 12, 12:49 pm EDT | Jeffrey S MathiesenChief Financial Officer | 4,000 | $10.00 | $40,000 | 7,927 | +102% | plan? |
| Aug 10, 2016 CForm 4 → | Aug 12, 12:49 pm EDT | Jeffrey S MathiesenChief Financial Officer | 3,927 | $6.71 | $26,334 | 3,927 | — | plan? |
| Aug 10, 2016 PForm 4 → | Aug 12, 12:47 pm EDT | Charles Bisgaier Ph.D.Chair & Chief Scientific Off., Director, 10% Owner | 51,750 | $10.00 | $517,500 | 1,244,440 | +4.34% | plan? |
| Aug 10, 2016 CJForm 4 → | Aug 12, 12:47 pm EDT | Charles Bisgaier Ph.D.Chair & Chief Scientific Off., Director, 10% Owner | 101,448 | $6.71 | $280,890 | 19,228 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| May 22, 2018 AForm 4 → | May 24, 4:31 pm EDT | Steven R. Gullans Ph.D.President & CEO, Director | 100,000 | — | — | 50,000 | — | |
| May 1, 2018 AForm 4 → | May 3, 4:32 pm EDT | Steven R. Gullans Ph.D.President & CEO, Director | 150,000 | — | — | 150,000 | — | |
| Jan 29, 2018 AForm 4 → | Jan 30, 5:12 pm EST | Andy SassineDirector | 10,800 | — | — | 10,800 | — | |
| Jan 29, 2018 AForm 4 → | Jan 30, 5:04 pm EST | Pedro LichtingerDirector | 10,800 | — | — | 10,800 | — | |
| Jan 29, 2018 AForm 4 → | Jan 30, 4:52 pm EST | Kenneth W KouskyDirector | 10,800 | — | — | 10,800 | — | |
| Jan 29, 2018 AForm 4 → | Jan 30, 4:44 pm EST | P. Kent HawrylukDirector | 10,800 | — | — | 10,800 | — | |
| Jan 29, 2018 AForm 4 → | Jan 30, 4:06 pm EST | Steven R. Gullans Ph.D.Interim President & CEO, Director | 60,000 | — | — | 60,000 | — | |
| Jan 28, 2018 AForm 4 → | Jan 30, 4:36 pm EST | Charles Bisgaier Ph.D.Chief Scien Officer & Chair, Director, 10% Owner | 48,000 | — | — | 48,000 | — | |
| Jan 28, 2018 AForm 4 → | Jan 30, 4:27 pm EST | Lee Scott GoldenChief Medical Officer | 148,000 | — | — | 148,000 | — | |
| Jan 28, 2018 AForm 4 → | Jan 30, 4:20 pm EST | Jeffrey S MathiesenChief Financial Officer | 48,000 | — | — | 48,000 | — | |
| Jan 28, 2018 AForm 4 → | Jan 30, 4:13 pm EST | Seth RenoChief Commercial Officer | 48,000 | — | — | 48,000 | — | |
| Aug 14, 2017 MForm 4 → | Aug 16, 4:10 pm EDT | Jeffrey S MathiesenChief Financial Officer | 3,207 | — | — | 0 | — | |
| Aug 10, 2017 MForm 4/A → | Aug 15, 4:22 pm EDT | Jeffrey S MathiesenChief Financial Officer | 3,000 | — | — | 45,093 | — | |
| Aug 10, 2017 MForm 4 → | Aug 11, 4:07 pm EDT | Jeffrey S MathiesenChief Financial Officer | 3,000 | — | — | 0 | — | amended |
| Jul 31, 2017 MForm 4 → | Aug 2, 4:11 pm EDT | Charles Bisgaier Ph.D.Chief Scientific Off. & Chair, Director, 10% Owner | 4,474 | — | — | 0 | — | |
| May 30, 2017 AForm 4 → | May 31, 4:25 pm EDT | Steven R. Gullans Ph.D.Interim President & CEO, Director | 60,000 | — | — | 60,000 | — | |
| Mar 28, 2017 AForm 4 → | Mar 29, 4:17 pm EDT | Lee Scott GoldenChief Medical Officer | 20,000 | — | — | 20,000 | — | |
| Mar 10, 2017 PForm 4 → | Mar 14, 6:07 pm EDT | Andy SassineDirector | 15,840 | $9.47 | $150,005 | 15,840 | — | |
| Mar 10, 2017 PForm 4 → | Mar 14, 5:57 pm EDT | Pedro LichtingerDirector | 7,920 | $9.47 | $75,002 | 7,920 | — | |
| Mar 10, 2017 PForm 4 → | Mar 14, 5:46 pm EDT | P. Kent HawrylukDirector | 18,750 | $9.47 | $177,563 | 18,750 | — | |
| Mar 10, 2017 PForm 4 → | Mar 14, 5:33 pm EDT | Steven R. Gullans Ph.D.Director | 39,599 | $9.47 | $375,003 | 39,599 | — | |
| Nov 25, 2016 AForm 4 → | Nov 29, 4:29 pm EST | Mina SoochPresident & CEO, Director | 120,000 | — | — | 600,000 | — | |
| Oct 5, 2016 AForm 4 → | Oct 6, 4:25 pm EDT | Lee Scott GoldenChief Medical Officer | 126,000 | — | — | 126,000 | — | |
| Sep 30, 2016 AForm 4 → | Oct 3, 4:32 pm EDT | Mina SoochPresident & CEO, Director | 120,000 | — | — | 480,000 | — | |
| Aug 10, 2016 CForm 4 → | Aug 12, 1:27 pm EDT | P. Kent HawrylukDirector | 7,457 | — | — | 0 | — | |
| Aug 10, 2016 CForm 4 → | Aug 12, 1:24 pm EDT | Andy SassineDirector | 75,080 | — | — | 0 | — | |
| Aug 10, 2016 CForm 4 → | Aug 12, 1:19 pm EDT | Pedro LichtingerDirector | — | — | — | 0 | — | |
| Aug 10, 2016 CForm 4 → | Aug 12, 1:15 pm EDT | Kenneth W KouskyDirector | 95,439 | — | — | 0 | — | |
| Aug 10, 2016 CForm 4 → | Aug 12, 1:09 pm EDT | Steven R. Gullans Ph.D.Director | — | — | — | 0 | — | |
| Aug 10, 2016 CForm 4 → | Aug 12, 1:01 pm EDT | Mina SoochPresident & CEO, Director | 11,078 | — | — | 0 | — | |
| Aug 10, 2016 CForm 4 → | Aug 12, 12:56 pm EDT | Carmen Daniela OniciuVice President | 2,237 | — | — | 0 | — | |
| Aug 10, 2016 CForm 4 → | Aug 12, 12:49 pm EDT | Jeffrey S MathiesenChief Financial Officer | — | — | — | 0 | — | |
| Aug 10, 2016 CForm 4 → | Aug 12, 12:47 pm EDT | Charles Bisgaier Ph.D.Chair & Chief Scientific Off., Director, 10% Owner | 59,561 | — | — | 0 | — | |
| Aug 4, 2016 AForm 4 → | Aug 8, 5:37 pm EDT | Andy SassineDirector | 60,000 | — | — | 60,000 | — | |
| Aug 4, 2016 AForm 4 → | Aug 8, 5:31 pm EDT | Pedro LichtingerDirector | 60,000 | — | — | 60,000 | — | |
| Aug 4, 2016 AForm 4 → | Aug 8, 5:23 pm EDT | Kenneth W KouskyDirector | 60,000 | — | — | 60,000 | — | |
| Aug 4, 2016 AForm 4 → | Aug 8, 5:15 pm EDT | P. Kent HawrylukDirector | 60,000 | — | — | 60,000 | — | |
| Aug 4, 2016 AForm 4 → | Aug 8, 5:06 pm EDT | Steven R. Gullans Ph.D.Director | 60,000 | — | — | 60,000 | — | |
| Aug 4, 2016 AForm 4 → | Aug 8, 4:56 pm EDT | Mina SoochPresident & CEO, Director, 10% Owner | 360,000 | — | — | 360,000 | — | |
| Aug 4, 2016 AForm 4 → | Aug 8, 4:46 pm EDT | Seth RenoChief Commercial Officer | 150,000 | — | — | 150,000 | — | |
| Aug 4, 2016 AForm 4 → | Aug 8, 4:39 pm EDT | Carmen Daniela OniciuVice President | 102,000 | — | — | 102,000 | — | |
| Aug 4, 2016 AForm 4 → | Aug 8, 4:31 pm EDT | Jeffrey S MathiesenChief Financial Officer | 210,000 | — | — | 210,000 | — | |
| Aug 4, 2016 AForm 4 → | Aug 8, 4:22 pm EDT | David LowenschussCLO & Secretary, 10% Owner | 78,000 | — | — | 78,000 | — | |
| Aug 4, 2016 AForm 4 → | Aug 8, 4:12 pm EDT | Charles Bisgaier Ph.D.Chief Scien. Officer & Chair, Director, 10% Owner | 150,000 | — | — | 150,000 | — |